Anika Therapeutics buy Barrington Research
Start price
03.11.23
/
50%
€19.70
Target price
03.11.24
€26.08
Performance (%)
22.84%
Price
02.05.24
€24.60
Summary
This prediction is currently active. The BUY prediction by Barrington_Research currently has a performance of 22.84%. This prediction currently runs until 03.11.24. The prediction end date can be changed by Barrington_Research at any time. Barrington_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Anika Therapeutics | 3.361% | 3.361% |
| iShares Core DAX® | -0.922% | -1.993% |
| iShares Nasdaq 100 | 0.371% | -0.868% |
| iShares Nikkei 225® | 2.224% | -5.187% |
| iShares S&P 500 | -0.026% | -0.918% |
Comments by Barrington_Research for this prediction
In the thread Anika Therapeutics diskutieren
Anika Therapeutics, Inc. (NASDAQ: ANIK) had its price target raised by analysts at Barrington Research from $24.00 to $28.00. They now have an "outperform" rating on the stock.
Ratings data for ANIK provided by MarketBeat
Stopped prediction by Barrington_Research for Anika Therapeutics
Anika Therapeutics
Start price
Target price
Perf. (%)
€20.60
03.01.24
03.01.24
€26.58
03.01.25
03.01.25
17.48%
02.05.24
02.05.24
